Micro-RNA as a new biomarker of activity of the cytochrome system P-450: Significance for predicting the antiplatelet action of P2Y12 receptor inhibitors

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

MicroRNAs are short non-coding RNAs that correlate with the levels of platelet activation which can be utilized as a biomarker when guiding P2Y12 inhibitors therapy. In this literature review, the perspectives of microRNA as a novel biomarker are discussed when guiding P2Y12 inhibitors therapy among the patients with coronary artery disease.

Cite

CITATION STYLE

APA

Rytkin, E. I., Mirzaev, K. B., Bure, I. V., & Sychev, D. A. (2019). Micro-RNA as a new biomarker of activity of the cytochrome system P-450: Significance for predicting the antiplatelet action of P2Y12 receptor inhibitors. Terapevticheskii Arkhiv, 91(8), 115–117. https://doi.org/10.26442/00403660.2019.08.000389

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free